GWAS Data Translating Into Improved Drug Safety, Researchers Say

At a session at the American Association for the Advancement of Science, GSK genetics head Lon Cardon argued that one of the most immediate practical applications of genome-wide association studies is in decreasing adverse drug events and improving drug safety.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.